<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04398719</url>
  </required_header>
  <id_info>
    <org_study_id>2000026320</org_study_id>
    <nct_id>NCT04398719</nct_id>
  </id_info>
  <brief_title>CBD-Microglia PET Study</brief_title>
  <official_title>Effect of Cannabidiol on Microglial Activation and Central Pain-Sensitization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial
      activation in healthy human subjects. Secondarily, this study aims to examine the effect of
      cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to examine the effect of cannabidiol (CBD), pre-treatment, as Epidiolex, on
      brain microglial activation in healthy human subjects using [11C]PBR28 PET imaging.
      Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on
      central pain-sensitization in healthy human subjects. Lastly, this research study will also
      examine the relationship between brain microglial activation and central pain sensitization
      with CBD pre-treatment.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 20, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microglial activation using [11C]PBR28 PET imaging</measure>
    <time_frame>10 Days</time_frame>
    <description>Difference in microglial activation ([11C]PBR28 VT levels) between the 2 groups (e.g., CBD vs. placebo)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Capsaicin-induced hyperalgesia</measure>
    <time_frame>10 Days</time_frame>
    <description>Difference in capsaicin-induced hyperalgesia between the 2 groups (e.g., CBD vs. placebo)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>CBD</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>CBD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>[11C]PBR28</intervention_name>
    <description>The radiotracer, [11C]PBR28, will be administered at the beginning of each PET scan</description>
    <arm_group_label>CBD</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>PET scan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low-dose lipopolysaccharide</intervention_name>
    <description>Subjects will receive intravenous lipopolysaccharide.</description>
    <arm_group_label>CBD</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>LPS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intradermal Capsaicin</intervention_name>
    <description>A small dose of capsaicin will be administered by intradermal injection.</description>
    <arm_group_label>CBD</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Men and women aged 18- 55 years

          2. No significant medical or neurological illness

          3. No implanted metal devices that may pose a risk during MRI scanning

          4. Within the annual permissible radiation exposure

          5. Able to provide written informed consent.

        Exclusion Criteria:

          1. Current use of any medications

          2. Presence of metal in the body

          3. Pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rajiv Radhakrishnan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rajiv Radhakrishnan, MD</last_name>
    <phone>203-974-7489</phone>
    <email>rajiv.radhakrishnan@yale.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohini Ranganathan, MD</last_name>
    <phone>(203)932-5711</phone>
    <phone_ext>2546</phone_ext>
    <email>mohini.ranganathan@yale.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Connecticut Mental Health Center</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>203-974-7775</phone>
    </contact>
    <investigator>
      <last_name>Rajiv Radhakrishnan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohini Ranganathan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 19, 2020</study_first_submitted>
  <study_first_submitted_qc>May 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yale University</investigator_affiliation>
    <investigator_full_name>Rajiv Radhakrishnan</investigator_full_name>
    <investigator_title>Assistant Professor of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>Control</keyword>
  <keyword>PET Scan</keyword>
  <keyword>MRI Scan</keyword>
  <keyword>Central Pain-Sensitization</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Capsaicin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

